Issued 2026-09-25 at $2.48 · now $2.48 (2026-09-25, +0.0% since)
Based on its own history, a month from the 2026-09-25 close, GNLX has typically landed between $1.52 and $3.69 — a range of −38.8% to +48.7% from the issuance price $2.48.
- Actual close
- Typical path (median)
- Middle 50% of outcomes
- 90% range
898 overlapping 1 month windows · 2023-01-26 – 2026-08-26 · basis climatology · forecast (batch). Base rate up 53.7% (90% CI 51.5–55.9%, ≈1,391 obs). Not a call on this stock — we have no evidence its odds differ.
The cone is anchored at the 2026-09-25 issuance close ($2.48) — the price the forecast resolves against on 2026-10-26, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.
Where GNLX has typically landed a month from the 2026-09-25 close of $2.48 — the range is history, not a prediction.
- now $2.48 (+0.0%)
- typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $2.39 (-3.6%)
- middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $2.02–$2.76
- 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $1.52–$3.69
| Start | Return | Max drop | Max rise |
|---|---|---|---|
| 3 worst | |||
| 2024-05-21 | −59.0% | −59.0% | +0.0% |
| 2024-05-22 | −53.1% | −57.6% | +0.0% |
| 2024-05-23 | −50.9% | −55.2% | +0.0% |
| 3 best | |||
| 2023-02-03 | +405.6% | +0.0% | +405.6% |
| 2023-02-16 | +374.5% | +0.0% | +374.5% |
| 2023-02-02 | +365.4% | −5.1% | +365.4% |
898 overlapping windows · 2023-01-26 – 2026-09-25 · not cherry-picked
Pending catalysts
- December 2026 — Trial primary completion: Phase 3 primary completion: Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076) (source, as of 2026-08-14)
- February 2027 — Trial primary completion: Phase 2 primary completion: Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer (source, as of 2026-08-14)
Public, scheduled events — dated attention, not a prediction of the outcome. See the FDA catalysts page for the historical base rate.
Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.
iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~4 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.Up-frequency and average month-over-month return · historical frequency, not a prediction
Reported insider & political trades
Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.
| Date | Person | Role | Action | Shares @ price | Value | Ownership Δ | vs S&P 1m | vs S&P 6m | Owned after | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-31 | Zindrick Thomas | director | Sale | 34,463 @ $2.67 | $92K | −2.7% of holding | not yet — horizon still open | not yet — horizon still open | 1,226,427 | Form 4 · filed 2 days after the trade |
| 2026-08-31 | Cappello Joseph | officer | Sale | 10,257 @ $2.74 | $28K | −3.1% of holding | not yet — horizon still open | not yet — horizon still open | 318,480 | Form 4 · filed 2 days after the trade |
| 2026-08-31 | Yu Yong | officer | Sale | 9,683 @ $2.75 | $27K | −3.6% of holding | not yet — horizon still open | not yet — horizon still open | 258,688 | Form 4 · filed 2 days after the trade |
| 2026-08-04 | Zindrick Thomas | director | Sale | 3,023 @ $2.95 | $9K | −0.2% of holding | −8.8% | not yet — horizon still open | 1,260,890 | Form 4 · filed same day |
| 2026-08-04 | Cappello Joseph | officer | Sale | 653 @ $2.95 | $2K | −0.2% of holding | −8.8% | not yet — horizon still open | 328,737 | Form 4 · filed same day |
| 2026-08-04 | Yu Yong | officer | Sale | 653 @ $2.94 | $2K | −0.2% of holding | −8.8% | not yet — horizon still open | 268,371 | Form 4 · filed same day |
| 2026-07-01 | Smither John W | director | Sale | 12,000 @ $2.91 | $35K | −11.6% of holding | +1.2% | not yet — horizon still open | 91,403 | Form 4 · filed 1 day after the trade |
| 2026-06-03 | Smalling Ralph | officer | Sale | 192 @ $2.93 | $563 | −0.3% of holding | +0.8% | not yet — horizon still open | 67,611 | Form 4 · filed 1 day after the trade |
| 2026-06-01 | Thomas John | director | Sale | 10,000 @ $2.98 | $30K | −2.1% of holding | −0.9% | not yet — horizon still open | 472,784 | Form 4 · filed 1 day after the trade |
| 2026-05-11 | Zindrick Thomas | director | Sale | 2,798 @ $2.94 | $8K | −0.5% of holding | +0.5% | not yet — horizon still open | 532,051 | Form 4 · filed 1 day after the trade |
| 2026-05-11 | Cappello Joseph | officer | Sale | 605 @ $2.97 | $2K | −0.4% of holding | +0.5% | not yet — horizon still open | 154,549 | Form 4 · filed 1 day after the trade |
| 2026-05-11 | Yu Yong | officer | Sale | 605 @ $2.97 | $2K | −0.4% of holding | +0.5% | not yet — horizon still open | 149,706 | Form 4 · filed 1 day after the trade |
| 2026-05-11 | Smalling Ralph | officer | Sale | 270 @ $2.98 | $804 | −0.4% of holding | +0.5% | not yet — horizon still open | 67,803 | Form 4 · filed 1 day after the trade |
| 2026-03-25 | Smalling Ralph | officer | Sale | 240 @ $2.51 | $602 | −0.4% of holding | −13.6% | −25.4% | 68,073 | Form 4 · filed 1 day after the trade |
| 2026-03-24 | Zindrick Thomas | director | Sale | 3,582 @ $2.42 | $9K | −0.7% of holding | −4.3% | −13.7% | 534,849 | Form 4 · filed 2 days after the trade |
| 2026-03-24 | Yu Yong | officer | Sale | 906 @ $2.42 | $2K | −0.6% of holding | −4.3% | −13.7% | 144,938 | Form 4 · filed 2 days after the trade |
| 2026-03-24 | Cappello Joseph | officer | Sale | 906 @ $2.42 | $2K | −0.6% of holding | −4.3% | −13.7% | 155,154 | Form 4 · filed 2 days after the trade |
| 2026-03-24 | Smalling Ralph | officer | Sale | 345 @ $2.42 | $835 | −0.5% of holding | −4.3% | −13.7% | 68,313 | Form 4 · filed 2 days after the trade |
| 2026-03-02 | Thomas John | director | Sale | 10,000 @ $2.90 | $29K | −2.0% of holding | −12.1% | −22.6% | 482,784 | Form 4 · filed 1 day after the trade |
| 2025-12-05 | Smalling Ralph | officer | Sale | 165 @ $4.69 | $774 | −0.2% of holding | −27.8% | −43.9% | 68,658 | Form 4 · filed 4 days after the trade |
| 2025-12-01 | Thomas John | director | Sale | 10,000 @ $5.00 | $50K | −2.0% of holding | −11.6% | −50.3% | 492,784 | Form 4 · filed 1 day after the trade |
| 2025-11-17 | Zindrick Thomas | director | Sale | 4,509 @ $5.37 | $24K | −0.8% of holding | −21.8% | −56.2% | 538,431 | Form 4 · filed 24 days after the trade |
| 2025-11-17 | Yu Yong | officer | Sale | 973 @ $5.37 | $5K | −0.7% of holding | −21.8% | −56.2% | 145,844 | Form 4 · filed 24 days after the trade |
| 2025-11-17 | Cappello Joseph | officer | Sale | 973 @ $5.37 | $5K | −0.6% of holding | −21.8% | −56.2% | 156,060 | Form 4 · filed 24 days after the trade |
| 2025-11-17 | Smalling Ralph | officer | Sale | 343 @ $5.37 | $2K | −0.5% of holding | −21.8% | −56.2% | 68,823 | Form 4 · filed 22 days after the trade |
| 2025-09-03 | Smalling Ralph | officer | Sale | 580 @ $3.36 | $2K | −0.8% of holding | +28.4% | −25.2% | 69,166 | Form 4 · filed 97 days after the trade |
| 2025-08-21 | Zindrick Thomas | director | Sale | 12,673 @ $3.33 | $42K | −2.3% of holding | +14.3% | −29.5% | 542,940 | Form 4 · filed 112 days after the trade |
| 2025-08-21 | Yu Yong | officer | Sale | 3,219 @ $3.36 | $11K | −2.1% of holding | +14.3% | −29.5% | 146,817 | Form 4 · filed 112 days after the trade |
| 2025-08-21 | Cappello Joseph | officer | Sale | 1,463 @ $3.36 | $5K | −0.9% of holding | +14.3% | −29.5% | 157,033 | Form 4 · filed 112 days after the trade |
| 2025-08-21 | Cappello Joseph | officer | Sale | 1,270 @ $3.33 | $4K | −0.8% of holding | +14.3% | −29.5% | 158,496 | Form 4 · filed 112 days after the trade |
| 2025-08-21 | Smalling Ralph | officer | Sale | 1,244 @ $3.36 | $4K | −1.8% of holding | +14.3% | −29.5% | 69,746 | Form 4 · filed 110 days after the trade |
| 2025-05-12 | Zindrick Thomas | director | Sale | 10,764 @ $2.92 | $31K | −5.3% of holding | −7.8% | +94.3% | 191,447 | Form 4 · filed 1 day after the trade |
| 2025-05-12 | Yu Yong | officer | Sale | 5,579 @ $2.92 | $16K | −10.5% of holding | −7.8% | +94.3% | 47,640 | Form 4 · filed 1 day after the trade |
| 2025-05-12 | Cappello Joseph | officer | Sale | 4,737 @ $2.92 | $14K | −8.3% of holding | −7.8% | +94.3% | 52,266 | Form 4 · filed 1 day after the trade |
| 2025-05-12 | Ryder Sean | officer | Sale | 4,475 @ $2.92 | $13K | −8.6% of holding | −7.8% | +94.3% | 47,621 | Form 4 · filed 1 day after the trade |
| 2025-05-12 | Smalling Ralph | officer | Sale | 1,259 @ $2.92 | $4K | −3.5% of holding | −7.8% | +94.3% | 34,760 | Form 4 · filed 1 day after the trade |
| 2024-12-30 | Tyree James L | director | Sale | 3,460 @ $2.46 | $9K | −7.0% of holding | +62.3% | +17.2% | 45,791 | Form 4 · filed same day |
| 2024-12-16 | Zindrick Thomas | director | Sale | 14,315 @ $2.34 | $33K | −27.7% of holding | +5.4% | +27.0% | 37,372 | Form 4 · filed 2 days after the trade |
| 2024-12-16 | Cappello Joseph | officer | Sale | 6,300 @ $2.34 | $15K | −30.1% of holding | +5.4% | +27.0% | 14,653 | Form 4 · filed 2 days after the trade |
| 2024-12-16 | Smalling Ralph | officer | Sale | 2,510 @ $2.34 | $6K | −13.3% of holding | +5.4% | +27.0% | 16,322 | Form 4 · filed 2 days after the trade |
| 2024-12-16 | Zak Lourie S. | officer | Sale | 2,103 @ $2.34 | $5K | −4.9% of holding | +5.4% | +27.0% | 40,802 | Form 4 · filed 2 days after the trade |
| 2024-09-13 | Szalay Aladar | tenPercentOwner | Sale | 33,080 @ $2.57 | $85K | −5.2% of holding | +4.3% | +51.2% | 599,821 | Form 4 · filed same day |
| 2024-09-12 | Szalay Aladar | tenPercentOwner | Sale | 31,777 @ $2.73 | $87K | −4.8% of holding | −6.2% | +37.6% | 632,901 | Form 4 · filed 1 day after the trade |
| 2024-09-11 | Szalay Aladar | tenPercentOwner | Sale | 31,376 @ $2.62 | $82K | −4.5% of holding | −3.5% | +28.6% | 664,678 | Form 4 · filed same day |
| 2024-09-11 | Tyree James L | director | Sale | 1,730 @ $2.60 | $4K | −3.5% of holding | −3.5% | +28.6% | 47,521 | Form 4 · filed 1 day after the trade |
| 2024-09-10 | Szalay Aladar | tenPercentOwner | Sale | 20,384 @ $2.51 | $51K | −2.8% of holding | −1.1% | +41.5% | 696,054 | Form 4 · filed 1 day after the trade |
| 2024-09-09 | Szalay Aladar | tenPercentOwner | Sale | 23,383 @ $2.70 | $63K | −3.2% of holding | −10.8% | +37.1% | 716,438 | Form 4 · filed 2 days after the trade |
| 2024-09-03 | Szalay Aladar | tenPercentOwner | Sale | 42,818 @ $2.09 | $90K | −5.5% of holding | +7.2% | +74.9% | 739,821 | Form 4 · filed 3 days after the trade |
| 2024-08-30 | Szalay Aladar | tenPercentOwner | Sale | 142,589 @ $2.17 | $310K | −15.4% of holding | +3.0% | +71.0% | 782,639 | Form 4 · filed same day |
| 2024-08-29 | Szalay Aladar | tenPercentOwner | Sale | 107,045 @ $1.98 | $212K | −10.4% of holding | +16.6% | +79.9% | 925,228 | Form 4 · filed 1 day after the trade |
| 2024-08-28 | Szalay Aladar | tenPercentOwner | Sale | 15,918 @ $2.05 | $33K | −1.5% of holding | +6.9% | +79.1% | 1,032,273 | Form 4 · filed 2 days after the trade |
| 2024-08-27 | Szalay Aladar | tenPercentOwner | Sale | 51,630 @ $2.11 | $109K | −4.7% of holding | −1.3% | +93.5% | 1,048,191 | Form 4 · filed same day |
| 2024-08-23 | Szalay Aladar | tenPercentOwner | Sale | 40,000 @ $2.29 | $91K | −3.5% of holding | −5.5% | +95.3% | 1,099,821 | Form 4 · filed 4 days after the trade |
| 2024-06-24 | Yu Yong | officer | Sale | 6,849 @ $2.12 | $15K | −38.7% of holding | −4.5% | −10.1% | 10,869 | Form 4 · filed 14 days after the trade |
| 2024-06-24 | Ryder Sean | officer | Sale | 5,496 @ $2.12 | $12K | −22.1% of holding | −4.5% | −10.1% | 19,388 | Form 4 · filed 14 days after the trade |
| 2024-06-24 | Jewett Caroline | officer | Sale | 4,961 @ $2.12 | $11K | −23.5% of holding | −4.5% | −10.1% | 16,174 | Form 4 · filed 14 days after the trade |
| 2024-05-29 | Yu Yong | officer | Purchase | 2,500 | — | ownership Δ n/a | −34.1% | −26.0% | 2,500 | Form 4 · filed 9 days after the trade |
| 2024-05-29 | Mirabelli Mary | director | Purchase | 8,000 | — | ownership Δ n/a | −34.1% | −26.0% | 8,000 | Form 4 · filed 9 days after the trade |
| 2024-05-29 | Ryder Sean | officer | Purchase | 10,000 | — | +1748.3% of holding | −34.1% | −26.0% | 10,572 | Form 4 · filed 9 days after the trade |
| 2024-05-29 | Ryder Sean | officer | Purchase | 10,000 | — | ownership Δ n/a | −34.1% | −26.0% | 10,000 | Form 4 · filed 9 days after the trade |
The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.
118 award / exercise / gift records — not counted as purchases
Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.
| Date | Person | Role | Action | Shares | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-06-16 | Cappello Joseph | officer | Award / grant | 174,841 | 329,390 | Form 4 |
| 2026-06-16 | Mirabelli Mary | director | Award / grant | 28,409 | 102,693 | Form 4 |
| 2026-06-16 | Mirabelli Mary | director | Award / grant | 31,566 | 31,566 | Form 4 |
| 2026-06-16 | Thomas John | director | Award / grant | 28,409 | 501,193 | Form 4 |
| 2026-06-16 | Thomas John | director | Award / grant | 31,566 | 31,566 | Form 4 |
| 2026-06-16 | Zindrick Thomas | director | Award / grant | 730,601 | 1,263,913 | Form 4 |
| 2026-06-16 | Tyree James L | director | Award / grant | 28,409 | 96,483 | Form 4 |
| 2026-06-16 | Tyree James L | director | Award / grant | 31,566 | 31,566 | Form 4 |
| 2026-06-16 | Groen Eric | officer | Award / grant | 233,957 | 233,957 | Form 4 |
| 2026-06-16 | Pulisic Matthew | officer | Award / grant | 278,906 | 278,906 | Form 4 |
| 2026-06-16 | Smither John W | director | Award / grant | 31,566 | 31,566 | Form 4 |
| 2026-06-16 | Smither John W | director | Award / grant | 28,409 | 103,403 | Form 4 |
| 2026-06-16 | Yu Yong | officer | Award / grant | 119,318 | 269,024 | Form 4 |
| 2026-01-02 | Litten Jason | officer | Award / grant | 275,000 | 275,000 | Form 4 |
| 2025-09-01 | Smalling Ralph | officer | Award / grant | 10,000 | 70,990 | Form 4 |
| 2025-09-01 | Yu Yong | officer | Disposition | 207,652 | 0 | Form 4 |
| 2025-09-01 | Cappello Joseph | officer | Disposition | 16,666 | 0 | Form 4 |
| 2025-09-01 | Cappello Joseph | officer | Award / grant | 16,666 | 16,666 | Form 4 |
| 2025-09-01 | Cappello Joseph | officer | Disposition | 80,000 | 0 | Form 4 |
| 2025-09-01 | Cappello Joseph | officer | Award / grant | 80,000 | 80,000 | Form 4 |
| 2025-09-01 | Cappello Joseph | officer | Disposition | 13,333 | 0 | Form 4 |
| 2025-09-01 | Cappello Joseph | officer | Award / grant | 13,333 | 13,333 | Form 4 |
| 2025-09-01 | Cappello Joseph | officer | Disposition | 65,000 | 0 | Form 4 |
| 2025-09-01 | Cappello Joseph | officer | Award / grant | 65,000 | 65,000 | Form 4 |
| 2025-09-01 | Smalling Ralph | officer | Disposition | 8,333 | 0 | Form 4 |
| 2025-09-01 | Smalling Ralph | officer | Award / grant | 8,333 | 8,333 | Form 4 |
| 2025-09-01 | Yu Yong | officer | Disposition | 207,652 | 0 | Form 4 |
| 2025-09-01 | Yu Yong | officer | Award / grant | 207,652 | 207,652 | Form 4 |
| 2025-09-01 | Yu Yong | officer | Disposition | 65,000 | 0 | Form 4 |
| 2025-09-01 | Yu Yong | officer | Award / grant | 65,000 | 65,000 | Form 4 |
| 2025-09-01 | Zindrick Thomas | director | Disposition | 925,000 | 0 | Form 4 |
| 2025-09-01 | Zindrick Thomas | director | Award / grant | 925,000 | 925,000 | Form 4 |
| 2025-09-01 | Zindrick Thomas | director | Disposition | 157,372 | 0 | Form 4 |
| 2025-09-01 | Zindrick Thomas | director | Award / grant | 157,372 | 157,372 | Form 4 |
| 2025-09-01 | Zindrick Thomas | director | Disposition | 23,568 | 0 | Form 4 |
| 2025-09-01 | Zindrick Thomas | director | Award / grant | 23,568 | 23,568 | Form 4 |
| 2025-09-01 | Zindrick Thomas | director | Disposition | 250,000 | 0 | Form 4 |
| 2025-09-01 | Zindrick Thomas | director | Award / grant | 250,000 | 250,000 | Form 4 |
| 2025-09-01 | Yu Yong | officer | Award / grant | 207,652 | 207,652 | Form 4 |
| 2025-09-01 | Yu Yong | officer | Disposition | 65,000 | 0 | Form 4 |
Source: SEC Form 4 filings. Each row links to its original filing.
Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.
Congressional disclosures
No congressional trades disclosed for this company.
Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.